PURPOSE
To investigate the success of conventional methods in the treatment of anisohyperopic amblyopia.
METHODS
A retrospective chart review of all patients with anisohyperopic amblyopia seen at the UCSD/Ratner Children’s Eye Center during a 42-month period was performed. The charts of 35 patients aged 3 to 14 years (mean age, 6.8 years) with 1.5 to 6.5 diopters of anisohyperopia were reviewed. Main outcome measures were the difference in refractive error and the pre- and post-treatment Snellen equivalent distance acuities. Treatment consisted of one or a combination of the following: spectacles, contact lenses, patching, and atropine. Binocularity was determined using the Titmus test. Compliance to treatment also was rated.
RESULTS
Thirteen (37.1%) patients were treated with spectacles alone, 11 (31.5%) were treated with a combination of atropine and patching, 8 (22.8%) were treated with patching alone, 2 (5.7%) received blurring contact lenses, and 1 (2.9%) patient was treated with atropine alone. The average pretreatment visual acuity was 20/108, with an improvement to an average of 20/27 at the termination of treatment. Ninety-four percent of the patients obtained a visual acuity of 20/40 or better.
CONCLUSIONS
Conventional methods of treatment are effective in improving vision and binocular status in anisohyperopia. Depending on the patient, only spectacles may be required.
J Pediatr Ophthalmol Strabismus 2006;43:207-211
AUTHORS
The authors are from the Department of Ophthalmology, UCSD/Ratner Children’s Eye Center, University of California, San Diego, California.
Originally submitted March 29, 2005.
Accepted for publication May 2, 2005.
Address reprint requests to David B. Granet, MD, Department of Ophthalmology, University of California, San Diego, La Jolla, CA 92093-0946.
Presented at the annual meeting of the American Association for Pediatric Ophthalmology and Strabismus; Seattle, WA; 2002.
The authors have no industry relationships to disclose.
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.
The material presented at or in any Vindico Medical Education continuing medical education activity does not necessarily reflect the views and opinions of Vindico Medical Education or SLACK Incorporated. Neither Vindico Medical Education or SLACK Incorporated, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/author may discuss the use of materials and/or products that have not yet been approved by the U.S. Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
